Autres langues Vertex Pharmaceuticals Incorporated

Actions

VRTX

US92532F1003

Produits pharmaceutiques

Temps réel estimé Cboe BZX Autres places de cotation 17:42:25 03/08/2026			Varia. 5j.	Varia. 1 janv.
471,18 ^USD	-1,24 %		-1,61 %	+3,96 %

13:18	La chute du pétrole soutient Wall Street avant l'ouverture ; l'Asie termine en ordre dispersé, l'Europe progresse	MT
07:36	Tout est sous contrôle ?

Autres langues

13:18	Falling Oil Boosts Wall Street Pre-Bell; Asia Mixed, Europe Up
12:26	Agenda de resultados empresariales del 3 al 7 de agosto de 2026
10:57	Calendario delle società: 3 - 7 agosto 2026
08:58	Unternehmenskalender vom 3. bis 7. August 2026
29/07	Abcellera Biologics Inc. Announces Collaboration with Vertex Pharmaceuticals Incorporated to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
21/07	Analystenempfehlungen: VAT, Belimo, Richemont, Salesforce, Goldman Sachs, Crowdstrike…
21/07	A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
20/07	Compañías que se deben tener muy en cuenta por técnico este lunes en Wall Street
13/07	American Academy of Orthopaedic Surgeons Launches New Pain Management Resource Center in Partnership with Curonix LLC Pacira Biosciences, Inc., Vertex Pharmaceuticals, and Viatris
08/07	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
08/07	The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy
08/07	Compañías que se deben tener muy en cuenta por técnico este miércoles
08/07	Vertex Receives FDA Approval Expansion For Exagamglogene Autotemcel And Novartis Receives EC Approval For Onasemnogene Abeparvovec
07/07	Vertex to Announce Second Quarter 2026 Financial Results on August 3rd
07/07	IBT company Crinetics to be acquired by Vertex for USD10 billion
07/07	Aktien New York Schluss: Samsung belastet Chip-Aktien - Dow im Minus
07/07	Top Midday Gainers
07/07	Vertex Pharmaceuticals' Acquisition of Crinetics Adds Rare-Disease Drugs, UBS Says
07/07	Top Midday Stories: Amazon Seeking at Least $25 Billion From US Bond Sale; Fiserv Explores Sale of STAR Debit Network
07/07	SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout \| Stock Movers
07/07	Global markets live: Broadcom, Meta, Walmart, Intel, AbbVie…
07/07	Aktien New York: Dow bleibt auf Rekordjagd - Chip-Aktien schwach
07/07	Cantor Sees 'Clear Strategic Rationale' Behind Vertex's Buy of Crinetics -- Market Talk
07/07	Vertex Signs Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance for ALYFTREK for the Treatment of Cystic Fibrosis